Can a simple test predict Alzheimer's before symptoms worsen?

NCT ID NCT06448403

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study aims to understand brain changes in people with mild cognitive impairment (MCI) and Alzheimer's disease. Researchers will use MRI, EEG, cognitive tests, and blood and stool samples to find differences between healthy individuals and those with cognitive impairment. The goal is to identify biomarkers that could help predict who will develop Alzheimer's and improve diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multimodal assessment including MRI, EEG, polysomnography, blood and fecal sample analysis, and cognitive tests
What this could lead to
If successful, this could lead to earlier detection of Alzheimer's disease and more precise classification of the condition.
What could go wrong
This is an observational study, so it won't directly test a treatment. The findings may not translate into a clinical test or change patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, LATE ONSET are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU)

    RECRUITING

    Trondheim, Trønderlag, 7030, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.